Quantification of Grapiprant and Its Stability Testing under Changing Environmental Conditions

Grapiprant is a new analgesic and anti-inflammatory drug belonging to the piprant class, approved in 2016 by the FDA Veterinary Medicine Center for the treatment of pain and inflammation associated with osteoarthritis in dogs. It acts as a highly selective antagonist of the EP4 receptor, one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gumułka, Paweł, Tarsa, Monika, Dąbrowska, Monika, Starek, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687689/
https://www.ncbi.nlm.nih.gov/pubmed/36359341
http://dx.doi.org/10.3390/biomedicines10112821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687689/
https://www.ncbi.nlm.nih.gov/pubmed/36359341
http://dx.doi.org/10.3390/biomedicines10112821

Ejemplares similares